Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2R | P25116 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1731448 | 0.99 | F2R (0.40) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1729513 | 0.91 | F2R (0.45) | F2RKDM4EMAPTRAB9ANPC1 | |
| SCHEMBL14449127 | 0.91 | F2R (0.43) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1732639 | 0.91 | F2R (0.44) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1729134 | 0.90 | F2R (0.44) | F2RKDM4EMAPTRAB9ANPC1 | |
| SCHEMBL14468845 | 0.90 | F2R (0.33) | F2R | |
| SCHEMBL14449115 | 0.90 | F2R (0.42) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1732632 | 0.89 | F2R (0.40) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1730798 | 0.89 | F2R (0.42) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1729841 | 0.88 | KDM4E (0.35) | F2RKDM4EMAPTRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7244730-B2 | 2-iminopyrrolidine derivatives | EISAI CO., LTD (JP) | 2007-07-17 | — | — | US | disclosed |
| EP-1391451-A1 | 2-IMINOPYRROLIDINE DERIVATES | Eisai Co., Ltd. (JP) | 2004-02-25 | — | — | EP | disclosed |